Amplification of HSD17B1 and ERBB2 in primary breast cancer

Oncogene

Volumn 22, Issue 1, 2003, Pages 34-40

  Gunnarsson, Cecilia ^a   Ahnström, Marie ^a   Kirschner, Kristina ^a   Olsson, Birgit ^a   Nordenskjöld, Bo ^a   Rutqvist, Lars Erik ^b   Skoog, Lambert ^b   Stål, Olle ^a,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

17q; 17 HSD; Breast cancer; ERBB2 estrogen; HSD17B1; Real time PCR

Indexed keywords

CYCLOPHOSPHAMIDE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CHROMOSOME 17Q; DRUG RESPONSE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; ONCOGENE ERBB2; ONCOGENE HSD17B1; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0037427071     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206078     Document Type: Article

References (30)

1. Bièche I and Lidereau R. (1995). Genes Chrom. Cancer, 14, 227-251.
2. Bièche I, Olivi M, Champème M-H, Vidaud D, Lidereau R and Vidaud M. (1998). Int J. Cancer, 78, 661-668.
3. Bièche I, Tomasetto C, Regnier CH, Moog-Lutz C, Rio MC and Lidereau R. (1996). Cancer Res., 56, 3886-3890.
4. Dowsett M. (1997). J. Steroid Biochem. Mol. Biol., 61, 261-266.
5. Ellis M, Coop A and Singh B. (2001). J. Clin. Oncol. 19, 3808-3816.
6. Feigelson SH, McKean-Cowdin R, Coetzee GA, Stram DO, Kolonel LN and Henderson BE. (2001). Cancer Res., 61, 785-789.
7. Gunnarsson C, Olsson B and Stål O. (2001). Cancer Res., 61, 8448-8451.
8. Järvinen TA, Tanner M, Rantanen V, Barlund M, Borg Å, Grenman S and Isola J. (2000). Am. J. Pathol., 156, 839-847.
9. Kauraniemi P, Barlund M, Monni O and Kallioniemi A. (2001). Cancer Res., 61, 8235-8240.
10. Labrie F, Luu-Thee V, Lin S-X, Labrie C, Simard J, Breton R and Belanger A. (1997). Steroids, 62, 148-158.
11. Latham C, Zhang A, Nalbanti A, Maner S, Zickert P, Belgen H and Zetterberg A. (2001). Cancer Genet. Cytogenet., 127, 16-23.
12. Luu-Thee V, Zhang Y, Poirier D and Labrie F. (1995). Biochem. Mol. Biol., 55, 581-587.
13. Mannermaa A, Peltoketo H, Winqvist R, Ponder BA, Kiviniemi H, Easton DF, Poutanen M, Isomaa V and Vihko R. (1994). Human Genet., 93, 319-324.
14. Miettinen M, Mustonen M, Poutanen M, Isomaa V and Vihko R. (1996). J. Biochem., 314, 839-845.
15. Miyoshi Y, Ando A, Shiba E, Taguchi T, Tamaki Y and Noguchi S. (2001). Int. J. Cancer, 94, 685-689.
16. Osborne RJ and Hamshere MG. (2000). Cancer Res., 60, 3706-3712.
17. Plummer S, Paris M, Myles J, Tubbs R, Crowe J and Casey G. (1997). Genes Chrom. Cancer, 20, 354-362.
18. Poutanen M, Isomaa V, Letho V-P and Vihko R. (1992). Int. J. Cancer, 50, 386-390.
19. Purohit A, Newman SP and Reed MJ. (2002). Breast Cancer Res., 4, 65-69.
20. Rèvillion F, Bonneterre J and Peyrat JP. (1998). Eur. J. Cancer, 34, 791-808.
21. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Buhm SE, Silverberg SG and Nagura H. (1996). J. Clin. Endocrin. Metabol., 11, 4042-4046.
22. Speirs V, Green AR and Atkin SL. (1998a). J. Steroid Biochem. Mol. Biol., 67, 267-274.
23. Speirs V, Green AR, Walton DS, Kerin MJ, Fox JN, Carleton PJ, Desai SB and Atkin SL. (1998b). Br. J. Cancer, 78, 1421-1429.
24. Speirs V, Walton DS, Hall M-C and Atkin SL. (1999). Br. J. Cancer, 81, 690-695.
25. Stål O, Sullivan S, Sun X-F, Wingern S and Nordenskjöld B. (1994). Cytometry, 16, 160-168.
26. Stål O, Borg Å, Fernö M, Källström A-C, Malmström P, Nordenskjöld B and members of the South Sweden Breast Cancer Group and the Southeast Sweden Breast Cancer Group. (2000). Ann. Oncol., 11, 1545-1550.
27. Suzuki T, Moriya T, Ariga N, Kanazawa M and Sasano H. (2000). Br. J. Cancer, 82, 518-523.
28. Utsumi T, Yoshimura N, Takeuchi S, Ando J, Maruta M, Maeda K and Harada N. (1999). Cancer Res., 59, 377-381.
29. Vihko P, Isomaa V and Ghosh D. (2001). Mol. Cell. Endocrin., 171, 71-76.
30. Yue W, Wang J, Hamilton C, Demers L and Sauten R. (1998). Cancer Res., 58, 927-932.